Aligos Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 444.11 K | $4.14 M | 0.00% | 4.28% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 412.00 K | $3.84 M | 0.00% | 3.97% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 335.94 K | $3.13 M | 0.00% | 3.24% |
| WOODLINE PARTNERS LP | 02/17/2026 | 289.17 K | $2.70 M | -38.24% | 2.79% |
| MARSHALL WACE, LLP | 02/13/2026 | 268.66 K | $2.50 M | 100.00% | 2.59% |
| VANGUARD GROUP INC | 01/29/2026 | 200.40 K | $1.87 M | 16.72% | 1.93% |
| SUMMITTX CAPITAL, L.P. | 02/17/2026 | 139.42 K | $1.30 M | 100.00% | 1.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 85.44 K | $796.34 K | 55.30% | 0.82% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 83.06 K | $774.07 K | 0.00% | 0.80% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 80.65 K | $751.65 K | 106.82% | 0.78% |
| HHLR ADVISORS, LTD. | 02/17/2026 | 76.25 K | $710.62 K | 0.00% | 0.74% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 71.25 K | $664.09 K | 100.00% | 0.69% |
| LPL FINANCIAL LLC | 02/11/2026 | 66.00 K | $615.12 K | 19.74% | 0.64% |
| CITADEL ADVISORS LLC | 02/17/2026 | 51.83 K | $483.09 K | 402.75% | 0.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 47.74 K | $445.14 K | 1.40% | 0.46% |
| JANE STREET GROUP, LLC | 02/12/2026 | 24.29 K | $226.41 K | 100.00% | 0.23% |
| XTX TOPCO LTD | 02/17/2026 | 23.05 K | $214.85 K | 100.00% | 0.22% |
| QUEST PARTNERS LLC | 02/09/2026 | 13.88 K | $129.32 K | 104.90% | 0.13% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 13.11 K | $122.17 K | 584.85% | 0.13% |
| BLACKROCK, INC. | 02/12/2026 | 13.04 K | $121.53 K | 0.00% | 0.13% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 13.00 K | $121.16 K | 100.00% | 0.13% |
| DRW SECURITIES, LLC | 02/12/2026 | 11.95 K | $111.37 K | 100.00% | 0.12% |
| HRT FINANCIAL LP | 02/12/2026 | 11.37 K | $106.00 K | 100.00% | 0.11% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/17/2026 | 10.00 K | $93.20 K | 900.00% | 0.10% |
| NORTHCREST ASSET MANANGEMENT, LLC | 01/08/2026 | 10.00 K | $84.10 K | 0.00% | 0.10% |
| FMR LLC | 02/17/2026 | 4.97 K | $46.34 K | 100.00% | 0.05% |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 02/13/2026 | 2.67 K | $24.92 K | 0.00% | 0.03% |
| MORGAN STANLEY | 02/13/2026 | 2.52 K | $23.49 K | -77.67% | 0.02% |
| ROYAL BANK OF CANADA | 02/17/2026 | 2.13 K | $20.00 K | 0.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.50 K | $13.98 K | -52.68% | 0.01% |
| CLEAR STREET MARKETS LLC | 02/17/2026 | 500 | $4.66 K | 100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 02/06/2026 | 400 | $3.73 K | -50.00% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 364 | $3.39 K | -97.75% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 306 | $2.85 K | -56.78% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 39 | $363 | -91.47% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 26 | $242 | 0.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 01/09/2026 | 4 | $38 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 3 | $28 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1 | $9 | 100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| READYSTATE ASSET MANAGEMENT LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aligos Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 52 institutional investors and hedge funds held shares of Aligos Therapeutics Inc. The most heavily invested institutionals were:
LPL Financial LLC: 51,500
UBS Group AG: 37,061
VANGUARD FIDUCIARY TRUST CO: 28,437
Golden State Wealth Management, LLC: 2,674
Vanguard Global Advisers, LLC: 936
WELLS FARGO & COMPANY/MN: 700
27.11% of Aligos Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.10 M shares in the last 24 months. This purchase volume represents approximately $42.87 M in transactions.